世界のホスファチジルイノシトール4,5ビスホスフェート3キナーゼ触媒サブユニットベータアイソフォーム市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A15067 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、82ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、ホスファチジルイノシトール4,5ビスホスフェート3キナーゼ触媒サブユニットベータアイソフォームのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ホスファチジルイノシトール4,5ビスホスフェート3キナーゼ触媒サブユニットベータアイソフォームの種類別市場規模（PQR-514、KA-2237、GSK-2636771、BAY-1082439、その他）、用途別市場規模（胃がん、転移性結腸直腸がん、骨髄線維症、腎細胞がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ホスファチジルイノシトール4,5ビスホスフェート3キナーゼ触媒サブユニットベータアイソフォームの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：AstraZeneca Plc、Bayer AG、Curis Inc、GlaxoSmithKline Plc、Karus Therapeutics Ltd、Novartis AG、PIQUR Therapeutics AG ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：PQR-514、KA-2237、GSK-2636771、BAY-1082439、その他 ・用途別分析2016年-2026年：胃がん、転移性結腸直腸がん、骨髄線維症、腎細胞がん、その他 ・ホスファチジルイノシトール4,5ビスホスフェート3キナーゼ触媒サブユニットベータアイソフォームの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ホスファチジルイノシトール4,5ビスホスフェート3キナーゼ触媒サブユニットベータアイソフォームのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ホスファチジルイノシトール4,5ビスホスフェート3キナーゼ触媒サブユニットベータアイソフォームのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ホスファチジルイノシトール4,5ビスホスフェート3キナーゼ触媒サブユニットベータアイソフォームの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ホスファチジルイノシトール4,5ビスホスフェート3キナーゼ触媒サブユニットベータアイソフォームの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
PQR-514
KA-2237
GSK-2636771
BAY-1082439
Others

Market segment by Application, can be divided into
Gastric Cancer
Metastatic Colorectal Cancer
Myelofibrosis
Renal Cell Carcinoma
Others

Market segment by players, this report covers
AstraZeneca Plc
Bayer AG
Curis Inc
GlaxoSmithKline Plc
Karus Therapeutics Ltd
Novartis AG
PIQUR Therapeutics AG

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform, with revenue, gross margin and global market share of Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform from 2019 to 2021.
Chapter 3, the Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform
1.2 Classification of Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform by Type
1.2.1 Overview: Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Type in 2020
1.2.3 PQR-514
1.2.4 KA-2237
1.2.5 GSK-2636771
1.2.6 BAY-1082439
1.2.7 Others
1.3 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market by Application
1.3.1 Overview: Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Gastric Cancer
1.3.3 Metastatic Colorectal Cancer
1.3.4 Myelofibrosis
1.3.5 Renal Cell Carcinoma
1.3.6 Others
1.4 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size & Forecast
1.5 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size and Forecast by Region
1.5.1 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Region, (2016-2021)
1.5.3 North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size and Prospect (2016-2026)
1.5.4 Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size and Prospect (2016-2026)
1.5.6 South America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Drivers
1.6.2 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Restraints
1.6.3 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Trends Analysis
2 Company Profiles
2.1 AstraZeneca Plc
2.1.1 AstraZeneca Plc Details
2.1.2 AstraZeneca Plc Major Business
2.1.3 AstraZeneca Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product and Solutions
2.1.4 AstraZeneca Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 AstraZeneca Plc Recent Developments and Future Plans
2.2 Bayer AG
2.2.1 Bayer AG Details
2.2.2 Bayer AG Major Business
2.2.3 Bayer AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product and Solutions
2.2.4 Bayer AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Bayer AG Recent Developments and Future Plans
2.3 Curis Inc
2.3.1 Curis Inc Details
2.3.2 Curis Inc Major Business
2.3.3 Curis Inc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product and Solutions
2.3.4 Curis Inc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Curis Inc Recent Developments and Future Plans
2.4 GlaxoSmithKline Plc
2.4.1 GlaxoSmithKline Plc Details
2.4.2 GlaxoSmithKline Plc Major Business
2.4.3 GlaxoSmithKline Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product and Solutions
2.4.4 GlaxoSmithKline Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 GlaxoSmithKline Plc Recent Developments and Future Plans
2.5 Karus Therapeutics Ltd
2.5.1 Karus Therapeutics Ltd Details
2.5.2 Karus Therapeutics Ltd Major Business
2.5.3 Karus Therapeutics Ltd Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product and Solutions
2.5.4 Karus Therapeutics Ltd Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Karus Therapeutics Ltd Recent Developments and Future Plans
2.6 Novartis AG
2.6.1 Novartis AG Details
2.6.2 Novartis AG Major Business
2.6.3 Novartis AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product and Solutions
2.6.4 Novartis AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Novartis AG Recent Developments and Future Plans
2.7 PIQUR Therapeutics AG
2.7.1 PIQUR Therapeutics AG Details
2.7.2 PIQUR Therapeutics AG Major Business
2.7.3 PIQUR Therapeutics AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product and Solutions
2.7.4 PIQUR Therapeutics AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 PIQUR Therapeutics AG Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Players Market Share
3.2.2 Top 10 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Players Market Share
3.2.3 Market Competition Trend
3.3 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue and Market Share by Type (2016-2021)
4.2 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Application (2016-2021)
5.2 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Type (2016-2026)
6.2 North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Application (2016-2026)
6.3 North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country
6.3.1 North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Country (2016-2026)
6.3.2 United States Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size and Forecast (2016-2026)
6.3.3 Canada Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size and Forecast (2016-2026)
6.3.4 Mexico Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Type (2016-2026)
7.2 Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Application (2016-2026)
7.3 Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country
7.3.1 Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Country (2016-2026)
7.3.2 Germany Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size and Forecast (2016-2026)
7.3.3 France Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size and Forecast (2016-2026)
7.3.5 Russia Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size and Forecast (2016-2026)
7.3.6 Italy Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Type (2016-2026)
8.2 Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Application (2016-2026)
8.3 Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Region
8.3.1 Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Region (2016-2026)
8.3.2 China Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size and Forecast (2016-2026)
8.3.3 Japan Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size and Forecast (2016-2026)
8.3.4 South Korea Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size and Forecast (2016-2026)
8.3.5 India Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size and Forecast (2016-2026)
8.3.7 Australia Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Type (2016-2026)
9.2 South America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Application (2016-2026)
9.3 South America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country
9.3.1 South America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Country (2016-2026)
9.3.2 Brazil Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size and Forecast (2016-2026)
9.3.3 Argentina Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Type (2016-2026)
10.2 Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Application (2016-2026)
10.3 Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country
10.3.1 Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Country (2016-2026)
10.3.2 Turkey Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size and Forecast (2016-2026)
10.3.4 UAE Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue (USD Million) by Region (2016-2021)
Table 5. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Region (2021-2026)
Table 6. AstraZeneca Plc Corporate Information, Head Office, and Major Competitors
Table 7. AstraZeneca Plc Major Business
Table 8. AstraZeneca Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product and Solutions
Table 9. AstraZeneca Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Bayer AG Corporate Information, Head Office, and Major Competitors
Table 11. Bayer AG Major Business
Table 12. Bayer AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product and Solutions
Table 13. Bayer AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Curis Inc Corporate Information, Head Office, and Major Competitors
Table 15. Curis Inc Major Business
Table 16. Curis Inc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product and Solutions
Table 17. Curis Inc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. GlaxoSmithKline Plc Corporate Information, Head Office, and Major Competitors
Table 19. GlaxoSmithKline Plc Major Business
Table 20. GlaxoSmithKline Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product and Solutions
Table 21. GlaxoSmithKline Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Karus Therapeutics Ltd Corporate Information, Head Office, and Major Competitors
Table 23. Karus Therapeutics Ltd Major Business
Table 24. Karus Therapeutics Ltd Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product and Solutions
Table 25. Karus Therapeutics Ltd Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Novartis AG Corporate Information, Head Office, and Major Competitors
Table 27. Novartis AG Major Business
Table 28. Novartis AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product and Solutions
Table 29. Novartis AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. PIQUR Therapeutics AG Corporate Information, Head Office, and Major Competitors
Table 31. PIQUR Therapeutics AG Major Business
Table 32. PIQUR Therapeutics AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product and Solutions
Table 33. PIQUR Therapeutics AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue (USD Million) by Players (2019-2021)
Table 35. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Share by Players (2019-2021)
Table 36. Breakdown of Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform by Company Type (Tier 1, Tier 2 and Tier 3)
Table 37. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Players Head Office, Products and Services Provided
Table 38. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Mergers & Acquisitions in the Past Five Years
Table 39. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform New Entrants and Expansion Plans
Table 40. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue (USD Million) by Type (2016-2021)
Table 41. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Share by Type (2016-2021)
Table 42. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Forecast by Type (2021-2026)
Table 43. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Application (2016-2021)
Table 44. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Forecast by Application (2021-2026)
Table 45. North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Type (2016-2021) & (USD Million)
Table 46. North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Type (2021-2026) & (USD Million)
Table 47. North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Application (2016-2021) & (USD Million)
Table 48. North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Application (2021-2026) & (USD Million)
Table 49. North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Country (2016-2021) & (USD Million)
Table 50. North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Country (2021-2026) & (USD Million)
Table 51. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Type (2016-2021) & (USD Million)
Table 52. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Type (2021-2026) & (USD Million)
Table 53. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Application (2016-2021) & (USD Million)
Table 54. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Application (2021-2026) & (USD Million)
Table 55. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Country (2016-2021) & (USD Million)
Table 56. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Country (2021-2026) & (USD Million)
Table 57. Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Type (2016-2021) & (USD Million)
Table 58. Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Type (2021-2026) & (USD Million)
Table 59. Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Application (2016-2021) & (USD Million)
Table 60. Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Application (2021-2026) & (USD Million)
Table 61. Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Region (2016-2021) & (USD Million)
Table 62. Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Region (2021-2026) & (USD Million)
Table 63. South America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Type (2016-2021) & (USD Million)
Table 64. South America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Type (2021-2026) & (USD Million)
Table 65. South America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Application (2016-2021) & (USD Million)
Table 66. South America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Application (2021-2026) & (USD Million)
Table 67. South America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Country (2016-2021) & (USD Million)
Table 68. South America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Country (2021-2026) & (USD Million)
Table 69. Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Type (2016-2021) & (USD Million)
Table 70. Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Type (2021-2026) & (USD Million)
Table 71. Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Application (2016-2021) & (USD Million)
Table 72. Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Application (2021-2026) & (USD Million)
Table 73. Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Country (2016-2021) & (USD Million)
Table 74. Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Picture
Figure 2. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Type in 2020
Figure 3. PQR-514
Figure 4. KA-2237
Figure 5. GSK-2636771
Figure 6. BAY-1082439
Figure 7. Others
Figure 8. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Application in 2020
Figure 9. Gastric Cancer Picture
Figure 10. Metastatic Colorectal Cancer Picture
Figure 11. Myelofibrosis Picture
Figure 12. Renal Cell Carcinoma Picture
Figure 13. Others Picture
Figure 14. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 15. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue and Forecast (2016-2026) & (USD Million)
Figure 16. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Region (2016-2026)
Figure 17. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Region in 2020
Figure 18. North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. South America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Middle East and Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Drivers
Figure 24. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Restraints
Figure 25. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Trends
Figure 26. AstraZeneca Plc Recent Developments and Future Plans
Figure 27. Bayer AG Recent Developments and Future Plans
Figure 28. Curis Inc Recent Developments and Future Plans
Figure 29. GlaxoSmithKline Plc Recent Developments and Future Plans
Figure 30. Karus Therapeutics Ltd Recent Developments and Future Plans
Figure 31. Novartis AG Recent Developments and Future Plans
Figure 32. PIQUR Therapeutics AG Recent Developments and Future Plans
Figure 33. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Share by Players in 2020
Figure 34. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share in 2020
Figure 36. Global Top 10 Players Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Share by Type in 2020
Figure 39. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Share Forecast by Type (2021-2026)
Figure 40. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Share by Application in 2020
Figure 41. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Share Forecast by Application (2021-2026)
Figure 42. North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Sales Market Share by Type (2016-2026)
Figure 43. North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Sales Market Share by Application (2016-2026)
Figure 44. North America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Country (2016-2026)
Figure 45. United States Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Sales Market Share by Type (2016-2026)
Figure 49. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Sales Market Share by Application (2016-2026)
Figure 50. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Country (2016-2026)
Figure 51. Germany Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Region (2016-2026)
Figure 59. China Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Sales Market Share by Type (2016-2026)
Figure 66. South America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Sales Market Share by Application (2016-2026)
Figure 67. South America Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source

---